Mark Sirotinskiy is a Crestwood, Illinois based male chiropractor who is specialized as General Chiropractor. Active license number of Mark Sirotinskiy as General Chiropractor is 038-011871 in Illinois. Mark Sirotinskiy is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Mark Sirotinskiy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Male
Practice Address:
13657 Cicero Ave, Crestwood, Illinois, 60445-1936
Phone:
708-396-2500
Fax:
708-396-8605
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1730484783
NPI Enumeration Date:
24 Jan, 2011
NPI Last Update On:
24 Jan, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mark Sirotinskiy are as mentioned below.
License Number
Specialization
State
Status
038-011871
Chiropractor
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7711 W 159th St, Suite 102 Tinley Park, Illinois
Zip:
60477-1329
Phone Number:
708-532-8080
Fax Number:
708-532-8383
Patients can reach Mark Sirotinskiy at 13657 Cicero Ave, Crestwood, Illinois or can call to book an appointment on 708-396-2500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.